| Dr Christopher Michael Lizana, DC | |
|
2404 Edenborn Ave, Metairie, LA 70001-1817 | |
| (504) 833-2225 | |
| Not Available |
| Full Name | Dr Christopher Michael Lizana |
|---|---|
| Gender | Male |
| Speciality | Chiropractic |
| Experience | 9 Years |
| Location | 2404 Edenborn Ave, Metairie, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093222671 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | 1808 (Louisiana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Stewart B. Fresh, Dc, Llc | 6305026378 | 2 |
News Archive
iRhythm Technologies, Inc., a healthcare information services company, today announced that it closed a $17 million Series E financing led by Novo A/S, a global life science investment firm.
Patients who choose to receive alternative therapy as treatment for curable cancers instead of conventional cancer treatment have a higher risk of death, according to researchers from the Cancer Outcomes, Public Policy and Effectiveness Research Center at Yale School of Medicine and Yale Cancer Center.
This post on RH Reality Check examines a Ugandan court case "alleging that the Ugandan government failed to protect the ... constitutional rights to life and health [of several women] by allowing them to die in ill-equipped and poorly managed public hospitals, or failing to provide them with basic maternal care."
OrthoAccel Technologies, Inc. has announced commercial plans for the United Kingdom that entail considerable business activity and economic impact. Last year, the Company hired a Director of Sales based in Wales. Recently, a full-market UK release of the AcceleDent System was reported. In conjunction with this product introduction at the British Orthodontic Conference, OrthoAccel has publicized plans to host a private lecture and reception to provide scientific data and education to doctors on this new technology that shortens orthodontic treatment time.
A solid tumor can cause muscle cells in the body to self-destruct. Many cancer patients die from the consequences. Now researchers are discovering more about how cancer cells in a tumor can take control of muscle cell wasting and trigger a chronic, serious condition.
› Verified 2 days ago
| Provider Name | Stewart B. Fresh, Dc, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1063718138 PECOS PAC ID: 6305026378 Enrollment ID: O20110208000634 |
News Archive
iRhythm Technologies, Inc., a healthcare information services company, today announced that it closed a $17 million Series E financing led by Novo A/S, a global life science investment firm.
Patients who choose to receive alternative therapy as treatment for curable cancers instead of conventional cancer treatment have a higher risk of death, according to researchers from the Cancer Outcomes, Public Policy and Effectiveness Research Center at Yale School of Medicine and Yale Cancer Center.
This post on RH Reality Check examines a Ugandan court case "alleging that the Ugandan government failed to protect the ... constitutional rights to life and health [of several women] by allowing them to die in ill-equipped and poorly managed public hospitals, or failing to provide them with basic maternal care."
OrthoAccel Technologies, Inc. has announced commercial plans for the United Kingdom that entail considerable business activity and economic impact. Last year, the Company hired a Director of Sales based in Wales. Recently, a full-market UK release of the AcceleDent System was reported. In conjunction with this product introduction at the British Orthodontic Conference, OrthoAccel has publicized plans to host a private lecture and reception to provide scientific data and education to doctors on this new technology that shortens orthodontic treatment time.
A solid tumor can cause muscle cells in the body to self-destruct. Many cancer patients die from the consequences. Now researchers are discovering more about how cancer cells in a tumor can take control of muscle cell wasting and trigger a chronic, serious condition.
› Verified 2 days ago
| Provider Name | Healthsource Of Mandeville, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1568175552 PECOS PAC ID: 0042662868 Enrollment ID: O20240117003166 |
News Archive
iRhythm Technologies, Inc., a healthcare information services company, today announced that it closed a $17 million Series E financing led by Novo A/S, a global life science investment firm.
Patients who choose to receive alternative therapy as treatment for curable cancers instead of conventional cancer treatment have a higher risk of death, according to researchers from the Cancer Outcomes, Public Policy and Effectiveness Research Center at Yale School of Medicine and Yale Cancer Center.
This post on RH Reality Check examines a Ugandan court case "alleging that the Ugandan government failed to protect the ... constitutional rights to life and health [of several women] by allowing them to die in ill-equipped and poorly managed public hospitals, or failing to provide them with basic maternal care."
OrthoAccel Technologies, Inc. has announced commercial plans for the United Kingdom that entail considerable business activity and economic impact. Last year, the Company hired a Director of Sales based in Wales. Recently, a full-market UK release of the AcceleDent System was reported. In conjunction with this product introduction at the British Orthodontic Conference, OrthoAccel has publicized plans to host a private lecture and reception to provide scientific data and education to doctors on this new technology that shortens orthodontic treatment time.
A solid tumor can cause muscle cells in the body to self-destruct. Many cancer patients die from the consequences. Now researchers are discovering more about how cancer cells in a tumor can take control of muscle cell wasting and trigger a chronic, serious condition.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christopher Michael Lizana, DC 2 Greenbriar Dr, Covington, LA 70433-4540 Ph: (985) 373-5003 | Dr Christopher Michael Lizana, DC 2404 Edenborn Ave, Metairie, LA 70001-1817 Ph: (504) 833-2225 |
News Archive
iRhythm Technologies, Inc., a healthcare information services company, today announced that it closed a $17 million Series E financing led by Novo A/S, a global life science investment firm.
Patients who choose to receive alternative therapy as treatment for curable cancers instead of conventional cancer treatment have a higher risk of death, according to researchers from the Cancer Outcomes, Public Policy and Effectiveness Research Center at Yale School of Medicine and Yale Cancer Center.
This post on RH Reality Check examines a Ugandan court case "alleging that the Ugandan government failed to protect the ... constitutional rights to life and health [of several women] by allowing them to die in ill-equipped and poorly managed public hospitals, or failing to provide them with basic maternal care."
OrthoAccel Technologies, Inc. has announced commercial plans for the United Kingdom that entail considerable business activity and economic impact. Last year, the Company hired a Director of Sales based in Wales. Recently, a full-market UK release of the AcceleDent System was reported. In conjunction with this product introduction at the British Orthodontic Conference, OrthoAccel has publicized plans to host a private lecture and reception to provide scientific data and education to doctors on this new technology that shortens orthodontic treatment time.
A solid tumor can cause muscle cells in the body to self-destruct. Many cancer patients die from the consequences. Now researchers are discovering more about how cancer cells in a tumor can take control of muscle cell wasting and trigger a chronic, serious condition.
› Verified 2 days ago
Trudy Ann Raiford, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 1908 Clearview Pkwy, Suite 103, Metairie, LA 70001 Phone: 504-888-1115 Fax: 504-888-8510 | |
Jeffrey Paul Vitenas, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 2701 Airline Dr Ste E, Metairie, LA 70001 Phone: 504-323-4956 | |
Dr. Chloe Horwood-little, DC Chiropractor Medicare: Medicare Enrolled Practice Location: 3544 W Esplanade Ave S Ste 1, Metairie, LA 70002 Phone: 504-888-1185 | |
Dr. Lychelle Zeno, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 3001 Division St Ste 202, Metairie, LA 70002 Phone: 504-262-8890 | |
Dr. Shawn Robert Smith, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 2709 Athania Pkwy, Metairie, LA 70002 Phone: 504-301-4231 Fax: 504-301-4253 | |
Gerry G Provance, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 2007 Clearview Pkwy, Metairie, LA 70001 Phone: 504-456-9296 Fax: 504-456-9799 | |
Southern Chiropractic, Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 110 Rosa Ave, Metairie, LA 70005 Phone: 504-832-1426 Fax: 504-832-1426 |